Zürcher Kantonal Bank

Grand Resort Bad Ragaz is situated in the Heidiland holiday region of Eastern Switzerland. Europe’s leading wellbeing and medical health resort dates back to 1242. The health resort is supplemented by the renowned Medical Health Centre, as well as the Swiss Olympic Medical Center. The resort has two golf courses, the Kursaal Business & Events Center, a broad range of cultural activities, and its casino.

embotech AG specializes in developing decision-making software solutions for autonomous systems. Founded in 2013 as a spin-off from the Automatic Control Laboratory at ETH Zurich, the company provides FORCES Pro, a numerical optimization software that enables the design of complex control systems. This software is utilized in various applications, including the control of wind turbines, planning the collision-free motion of autonomous drones, and the development of advanced driver assistance systems. Additionally, it supports precision landing of spacecraft on other planets and the recovery of reusable rockets. Embotech's solutions cater to sectors such as automotive, energy, and robotics, aiming to enhance safety, productivity, and energy efficiency in automated decision-making processes. The company is headquartered in Zurich, Switzerland.

Lymphatica Medtech SA is a Swiss company focused on designing and manufacturing medical devices for the treatment of lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed LymphoDrain, an innovative medical device that aims to re-establish lymphatic circulation. This system includes an active implantable lymphatic bypass, featuring a magnetically controlled micropump and subcutaneous catheters that facilitate the internal drainage of lymphatic fluid from multiple points within the affected limb. Lymphatica Medtech also produces essential components for LymphoDrain, such as the micropump head and wearable controller, providing a minimally invasive solution for individuals suffering from persistent lymphedema.

Complementa is a Swiss firm based in Saint Gallen, founded in 1984, that specializes in providing consolidated performance reporting, accounting, investment consulting, and investment control services. The firm assists investors by planning, designing, and monitoring their investment and financing processes, ensuring that they have the necessary support to make informed decisions.

Synthara AG, a Swiss semiconductor startup founded in 2019 and based in Zurich, specializes in designing advanced smart sensors for industrial Internet of Things (IoT) applications and other energy-sensitive uses. The company focuses on developing energy-efficient computational AI chips tailored for various applications, including wearables, health monitoring, augmented reality/virtual reality, and aerospace technologies. Its flagship product, ComputeRAM, serves as a drop-in replacement for traditional SRAM, enabling complex calculations to be performed directly in memory. This innovation significantly reduces CPU workload, enhances system performance, and improves efficiency, particularly for AI applications. Synthara's technology is processor-type agnostic, compatible with architectures such as RISC-V, ARM, and x86, allowing seamless integration into existing microcontroller platforms. By empowering chipmakers and device manufacturers, Synthara aims to lower costs, accelerate time to market, and foster new avenues for innovation in the semiconductor industry.

Microcaps AG is a company based in Zurich, Switzerland, specializing in the development of innovative microencapsulation technology. Founded in 2018, it focuses on creating a scalable production system for precise microcapsules and microparticles using advanced microfluidics. The company's devices enable the fabrication of monodisperse capsules and emulsions of various sizes, providing tailored solutions for drug delivery, probiotic encapsulation, and enhancing the stability of pharmaceutical agents and fragrances in cosmetic products. Microcaps aims to offer a fully automated encapsulation micro-factory that ensures size control and precise dosing, significantly improving production efficiency and throughput rates compared to conventional methods.

Bcomp Ltd. is a manufacturer based in Fribourg, Switzerland, specializing in natural fiber composites. Founded in 2003, the company produces innovative products such as ampliTex, a natural flax fiber available in various forms, bCores, a lightweight wood core, and powerRibs, a reinforcement material made from natural fibers. Bcomp's technologies, developed from years of research and patented innovations, allow for the creation of structural components that can effectively replace traditional materials like aluminum and carbon fiber. The company serves diverse industries, including sports, automotive, acoustics, aerospace, electronics, design, and leisure, focusing on enhancing efficiency in weight, rigidity, shock absorption, and damping. Bcomp collaborates closely with its customers to tailor solutions that meet specific needs while continuing to strengthen its research and development efforts through academic partnerships.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.

Odne is a medtech startup based in Renens, Switzerland, specializing in innovative implant technology for endodontics. Founded in 2018, the company focuses on the development of light-active medical fillers that facilitate the creation of implants directly within the body through a minimally invasive approach. This technology allows physicians to perform surgeries using an access channel of less than half a millimeter in diameter, significantly reducing surgical time and enhancing patient outcomes. By providing elegant solutions for complex procedures, Odne aims to improve the efficiency and effectiveness of medical interventions in the field of endodontics.

Food Brewer AG is a Switzerland-based company specializing in the development of food and food ingredients through innovative plant cell culture technologies. By utilizing large-scale cultivation methods akin to beer brewing, Food Brewer offers alternatives to conventional agriculture, thereby addressing challenges related to geographic, climatic, and ethical uncertainties in food production. The company focuses on creating sustainable ingredients, including cocoa, coffee, nuts, and grains, which cater to the needs of the food industry. Through its research and development efforts, Food Brewer aims to provide clients with reliable and resource-efficient options for food sourcing.

Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.

Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.

Aesyra SA, founded in 2017 and based in Lausanne, Switzerland, specializes in the design and manufacture of medical devices focused on managing sleep disorders. The company's flagship product, AesyBite, is an intra-oral sensor that monitors and alleviates sleep bruxism, a condition characterized by teeth grinding during sleep. Aesyra's technology enables dental professionals to conduct intraoral measurements while patients sleep, allowing for the detection of bruxism and other sleep-related issues, such as obstructive sleep apnea. By providing accurate monitoring and biofeedback alternatives, Aesyra aims to help healthcare providers reduce damage to dental prostheses caused by occlusal problems and improve overall sleep quality for their patients.

Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes microscopic worms for substance testing in pharmaceutical, chemical, and cosmetic industries. Their flagship product, the Caenorhabditis elegans-on-chip, integrates the use of these organisms for in vivo testing with a fully automated platform for in vitro culture, treatment, and analysis. This technology facilitates comprehensive toxicity testing, drug discovery, and anthelmintic testing applications, allowing clients to evaluate biological responses observable only at the whole-organism level. Nagi Bioscience aims to transform traditional testing methodologies by introducing its unique "Organism-on-Chip" technology.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

UniSieve Ltd, founded in 2018 and headquartered in Zurich, Switzerland, develops and manufactures advanced molecular sieving membranes that enable efficient separation solutions across various industries. The company's innovative platform technology integrates molecular sieves with polymeric membranes to facilitate applications such as chemical feedstock purification, biogas upgrading, gas and liquid separation, and specialized uses in sensing and space-related projects. UniSieve's technology is designed to enhance energy efficiency in size-based purification processes, supporting clients in reducing carbon dioxide emissions, improving recycling rates, and lowering operational costs.

Nexoya AG is a Zurich-based company founded in 2018 that specializes in developing a digital marketing platform designed to enhance marketing performance through artificial intelligence. The platform provides insights into marketing data and actionable advice, allowing clients to optimize their marketing campaigns and effectively allocate their advertising budgets across various channels. By collecting key performance indicators from tools such as Google Ads and Facebook, Nexoya's AI-driven algorithm evaluates the most cost-effective use of advertising funds, leading to a potential increase in return on ad spend. The platform also features predictive analytics, cross-channel reporting, and anomaly detection, which assist clients in planning and executing their marketing strategies with maximum efficiency.

Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.

tado° GmbH is a technology company based in Munich, Germany, with an additional office in London, United Kingdom. Founded in 2010, it specializes in developing and marketing innovative home climate control systems that enhance the efficiency of heating and cooling in residential and small business environments. The company's products integrate a hardware-software combination that leverages real-time data on resident behavior, weather forecasts, and building characteristics to optimize climate management. tado° sells its solutions through both retail outlets and online platforms, effectively bringing Internet of Things technology to the cleantech market.

Medyria AG is a Swiss medtech company based in Winterthur, specializing in sensor-based catheter navigation and sensing systems for cardiovascular procedures. Founded in 2012, the company offers a range of innovative products, including a catheter positioning system designed for X-ray and C-dye free minimally invasive interventions, as well as Flowcath, which measures blood flow. Their Trackcath technology processes flow data to enhance catheter tracking, while their OEM flow sensor utilizes proprietary technology for measuring blood and physiological fluid flow. Medyria aims to enhance the safety and effectiveness of endovascular procedures, ultimately improving patient outcomes and reducing procedural complications and costs.

Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.

Skribble is a Zurich-based platform that specializes in electronic signatures, enabling users to sign contracts digitally while ensuring that these signatures carry the same legal weight as handwritten ones under Swiss and EU law. Founded in 2018, Skribble provides a user-friendly interface that allows individuals and businesses to sign documents with a few clicks, streamlining the process of contract management. The platform incorporates signature management systems that facilitate the identification of signers, ensuring compliance with legal requirements. Through its services, Skribble aims to simplify the process of creating legally binding agreements in a digital format.

Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.

Smeetz SA is an online booking platform based in Lausanne, Switzerland, that specializes in the leisure and entertainment industry. Founded in 2016, the company offers a comprehensive suite of solutions designed to streamline event organization and promotion. Its platform incorporates AI-powered tools for sales, marketing, reservation management, ticket booking, and distribution. Smeetz employs dynamic pricing strategies and data analytics to help venues optimize revenue and enhance operational efficiency. The platform also includes features such as a booking widget, cross-channel sales, access control, payment methods, and customizable ticket solutions. By unifying commerce and embedding financial tools, Smeetz aims to transform the customer experience in the leisure sector, enabling businesses to thrive in a competitive environment.

Odne is a medtech startup based in Renens, Switzerland, specializing in innovative implant technology for endodontics. Founded in 2018, the company focuses on the development of light-active medical fillers that facilitate the creation of implants directly within the body through a minimally invasive approach. This technology allows physicians to perform surgeries using an access channel of less than half a millimeter in diameter, significantly reducing surgical time and enhancing patient outcomes. By providing elegant solutions for complex procedures, Odne aims to improve the efficiency and effectiveness of medical interventions in the field of endodontics.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.

Sleepiz AG, based in Zurich, Switzerland, specializes in manufacturing a non-contact sleep monitoring device aimed at enhancing healthcare accessibility in home environments. Incorporated in 2018, the company's innovative product is designed to be placed on a bedside table, where it accurately measures patients' breathing patterns, heart rate, and body movements using advanced wireless millimeter wave technology and artificial intelligence. This device not only facilitates the diagnosis of sleep disorders but also enables long-term monitoring of chronic diseases, allowing healthcare providers to track patient progression and implement timely interventions for improved treatment outcomes. Through its user-friendly and precise approach, Sleepiz is positioned to significantly contribute to patient-centric disease management.

9T Labs AG, founded in 2018 and based in Zürich, Switzerland, specializes in manufacturing 3D printers that produce carbon composite parts. The company integrates advanced software, additive manufacturing, and industry-standard materials to offer a digital composite production solution. Utilizing its proprietary Additive Fusion Technology (AFT), 9T Labs enables manufacturers to create lightweight structural components with precise 3D fiber orientation, facilitating mass production at reduced costs. The intuitive design software supports optimal fiber placement, while automated production equipment enhances efficiency across the entire value chain. The technology allows for the efficient production of high-performance parts, including applications in drones and prosthetics, making it accessible for engineers and manufacturers alike.

Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.

Odne is a medtech startup based in Renens, Switzerland, specializing in innovative implant technology for endodontics. Founded in 2018, the company focuses on the development of light-active medical fillers that facilitate the creation of implants directly within the body through a minimally invasive approach. This technology allows physicians to perform surgeries using an access channel of less than half a millimeter in diameter, significantly reducing surgical time and enhancing patient outcomes. By providing elegant solutions for complex procedures, Odne aims to improve the efficiency and effectiveness of medical interventions in the field of endodontics.

Nanoleq AG, established in 2017 and based in Zurich, Switzerland, specializes in the development and manufacturing of innovative electric cables using stretchable electronics. As a spinoff from ETH Zurich, the company focuses on integrating electronic functionalities into textiles, particularly for health monitoring. Its products utilize advanced conductive silicone technology to create soft sensors capable of recording vital signs such as heartbeat, electrocardiograms, and breathing patterns through comfortable and washable garments. These sensors are designed for various applications, including healthcare, sports, and workwear, with the aim of setting a standard in the health-monitoring textile market. Nanoleq is committed to facilitating the rapid development and widespread adoption of smart textiles across multiple sectors, including robotics and aerospace.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

xorlab AG is a Swiss cybersecurity company established in 2015, specializing in advanced defense solutions for email communication. The company has developed the xorlab ActiveGuard platform, which protects organizations from sophisticated threats such as spear-phishing, impersonation, ransomware, and zero-day exploits. By analyzing and learning from legitimate communication behaviors, ActiveGuard enhances email security for businesses, particularly in the financial services and high-tech sectors. Additionally, xorlab offers xorlab ThreatAnalyst, which supports security operations teams in identifying and mitigating emerging attacks. With a dedicated team of 14 professionals, xorlab safeguards over 50,000 mailboxes and processes more than 1.5 million emails daily, helping clients reduce the risk of breaches and lower operational costs through automation and proactive defense strategies.

Seervision AG, a Swiss startup founded in 2016 and based in Zurich, specializes in developing innovative software for camera automation aimed at enhancing video production efficiency. Originally conceived at ETH Zurich to improve live lecture recordings, the company has evolved into a dynamic enterprise with over 30 employees. The Seervision Suite now automates workflows primarily for corporate studios, stage events, and educational spaces. By leveraging advanced video analysis algorithms and technologies such as motion control, computer vision, and machine learning, Seervision enables fully automated productions, including autonomous camera tracking and facial recognition. This integration simplifies live production workflows, making it easier for users to manage hybrid meeting experiences and other video production needs.

Scewo AG, founded in 2017 and headquartered in Winterthur, Switzerland, specializes in designing and manufacturing innovative electric wheelchairs tailored for individuals with mobility impairments. The company has developed a unique stair-climbing wheelchair that integrates both wheels and tracks, allowing for enhanced maneuverability over various terrains, including curbs, tram tracks, grass, and uneven surfaces. This self-balancing wheelchair features an active control system that maintains stability and levelness, enabling users to navigate obstacles with ease. Users can control the chair through a joystick or by shifting their body weight, providing a versatile solution to improve mobility and independence for those with disabilities.

Sleepiz AG, based in Zurich, Switzerland, specializes in manufacturing a non-contact sleep monitoring device aimed at enhancing healthcare accessibility in home environments. Incorporated in 2018, the company's innovative product is designed to be placed on a bedside table, where it accurately measures patients' breathing patterns, heart rate, and body movements using advanced wireless millimeter wave technology and artificial intelligence. This device not only facilitates the diagnosis of sleep disorders but also enables long-term monitoring of chronic diseases, allowing healthcare providers to track patient progression and implement timely interventions for improved treatment outcomes. Through its user-friendly and precise approach, Sleepiz is positioned to significantly contribute to patient-centric disease management.

RoomPriceGenie AG, founded in 2017 and headquartered in Steinhausen, Switzerland, specializes in developing revenue management software for hotels, apartments, and vacation rentals. The platform employs advanced dynamic pricing algorithms and real-time analytics to optimize room pricing based on market demand and occupancy levels. It offers features such as automated pricing adjustments, manual control options, and seamless integration with various property management systems and channel managers. This allows users to update all prices with a single click, enhancing operational efficiency. RoomPriceGenie is designed for small to medium-sized hotels, providing a user-friendly interface and excellent customer support to help clients boost their revenue effectively.

Eldico Scientific AG, founded in 2019 and based in Villigen, Switzerland, specializes in the development and manufacturing of electron diffractometers designed for the analysis of solid compounds. The company's innovative instruments enable researchers in various fields, including pharmaceuticals, agrochemicals, and advanced materials, to characterize nano-crystalline systems that were previously difficult to measure. By providing tools for nano-crystallographic investigations, Eldico aims to enhance the efficiency and cost-effectiveness of structural information gathering, thereby accelerating the drug discovery and development process. The company has made significant strides in the field, achieving proof of concept for its technology in collaboration with leading Swiss research institutions, and has received recognition for its contributions to scientific advancement.

Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.

Nexoya AG is a Zurich-based company founded in 2018 that specializes in developing a digital marketing platform designed to enhance marketing performance through artificial intelligence. The platform provides insights into marketing data and actionable advice, allowing clients to optimize their marketing campaigns and effectively allocate their advertising budgets across various channels. By collecting key performance indicators from tools such as Google Ads and Facebook, Nexoya's AI-driven algorithm evaluates the most cost-effective use of advertising funds, leading to a potential increase in return on ad spend. The platform also features predictive analytics, cross-channel reporting, and anomaly detection, which assist clients in planning and executing their marketing strategies with maximum efficiency.

Apiax AG, founded in 2017 and based in Zürich, Switzerland, specializes in developing digital tools for managing financial regulations. The company provides an embedded compliance solution that allows financial institutions, including banks and FinTech companies, to transform complex regulations into user-friendly digital compliance rules. This technology enables clients to integrate compliance seamlessly into their existing applications and processes, facilitating faster decision-making and addressing pressing regulatory questions. By leveraging a high-performance architecture and machine learning, Apiax helps organizations navigate regulatory challenges, seize business opportunities, and reduce compliance costs. The company's presence extends beyond Switzerland, with additional offices in Lisbon and London.

Microcaps AG is a company based in Zurich, Switzerland, specializing in the development of innovative microencapsulation technology. Founded in 2018, it focuses on creating a scalable production system for precise microcapsules and microparticles using advanced microfluidics. The company's devices enable the fabrication of monodisperse capsules and emulsions of various sizes, providing tailored solutions for drug delivery, probiotic encapsulation, and enhancing the stability of pharmaceutical agents and fragrances in cosmetic products. Microcaps aims to offer a fully automated encapsulation micro-factory that ensures size control and precise dosing, significantly improving production efficiency and throughput rates compared to conventional methods.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.

Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.

Metaco is a Swiss company that specializes in providing institutional digital asset management solutions. It offers a comprehensive orchestration platform designed for financial institutions to issue, secure, manage, and trade digital assets. Metaco's platform supports the entire lifecycle of asset tokens, including the management of cryptocurrencies, tokens, and smart contracts. By utilizing advanced blockchain technologies, the company ensures a secure and efficient environment for digital asset management. Additionally, Metaco's solutions incorporate risk management to balance asset security and liquidity, allowing institutions to connect with over 50 exchanges, brokers, and market makers, thereby facilitating seamless trading across various asset classes such as equities, bonds, and derivatives.

Positrigo AG is a Swiss company based in Zurich that specializes in the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on making functional brain imaging accessible for early detection of neurodegenerative diseases, particularly Alzheimer's disease. The company provides advanced scanning solutions that aid in diagnostics, treatment monitoring, and the development of new therapies for conditions such as Lewy body dementia, vascular dementia, and frontotemporal dementia. By enabling early diagnosis in an affordable manner, Positrigo aims to improve patient outcomes and support healthcare professionals in managing these complex medical conditions.

xorlab AG is a Swiss cybersecurity company established in 2015, specializing in advanced defense solutions for email communication. The company has developed the xorlab ActiveGuard platform, which protects organizations from sophisticated threats such as spear-phishing, impersonation, ransomware, and zero-day exploits. By analyzing and learning from legitimate communication behaviors, ActiveGuard enhances email security for businesses, particularly in the financial services and high-tech sectors. Additionally, xorlab offers xorlab ThreatAnalyst, which supports security operations teams in identifying and mitigating emerging attacks. With a dedicated team of 14 professionals, xorlab safeguards over 50,000 mailboxes and processes more than 1.5 million emails daily, helping clients reduce the risk of breaches and lower operational costs through automation and proactive defense strategies.

Skribble is a Zurich-based platform that specializes in electronic signatures, enabling users to sign contracts digitally while ensuring that these signatures carry the same legal weight as handwritten ones under Swiss and EU law. Founded in 2018, Skribble provides a user-friendly interface that allows individuals and businesses to sign documents with a few clicks, streamlining the process of contract management. The platform incorporates signature management systems that facilitate the identification of signers, ensuring compliance with legal requirements. Through its services, Skribble aims to simplify the process of creating legally binding agreements in a digital format.

PXL Vision AG, founded in 2017 and headquartered in Zurich, Switzerland, specializes in the design and development of identity verification and customer onboarding software solutions. Its flagship product, Daego, employs advanced computer vision and machine learning technologies to create trusted digital identities. This cross-platform solution is tailored to meet the needs of various industries, including insurance, fintech, and healthcare, by automating the verification of identity documents and performing facial biometric checks to ensure that users are legitimate and the rightful owners of their documents. By facilitating secure and efficient customer onboarding, PXL Vision aims to enhance conversion rates, reduce costs associated with compliance, and mitigate identity fraud. With research and development centers in Novi Sad, Serbia, and Yerevan, Armenia, PXL Vision is dedicated to establishing a foundation of trust in digital interactions through unbiased and verifiable identities.

Klepsydra Technologies GmbH, founded in 2017 and based in Zurich, Switzerland, specializes in software engineering and cloud computing tools for embedded systems. The company provides a lightweight, platform-agnostic software development toolset aimed at facilitating the creation of high-performance applications in sectors such as aerospace, robotics, and smart mobility. Klepsydra's offerings are designed to accelerate the development of complex embedded software while optimizing computational performance for demanding tasks, such as sensor fusion and image processing. By enabling faster and more accessible innovation processes, Klepsydra serves as a valuable resource across various industries, contributing to advancements in autonomous technologies and other computationally intensive applications.

Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes microscopic worms for substance testing in pharmaceutical, chemical, and cosmetic industries. Their flagship product, the Caenorhabditis elegans-on-chip, integrates the use of these organisms for in vivo testing with a fully automated platform for in vitro culture, treatment, and analysis. This technology facilitates comprehensive toxicity testing, drug discovery, and anthelmintic testing applications, allowing clients to evaluate biological responses observable only at the whole-organism level. Nagi Bioscience aims to transform traditional testing methodologies by introducing its unique "Organism-on-Chip" technology.

Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.

Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.

Apiax AG, founded in 2017 and based in Zürich, Switzerland, specializes in developing digital tools for managing financial regulations. The company provides an embedded compliance solution that allows financial institutions, including banks and FinTech companies, to transform complex regulations into user-friendly digital compliance rules. This technology enables clients to integrate compliance seamlessly into their existing applications and processes, facilitating faster decision-making and addressing pressing regulatory questions. By leveraging a high-performance architecture and machine learning, Apiax helps organizations navigate regulatory challenges, seize business opportunities, and reduce compliance costs. The company's presence extends beyond Switzerland, with additional offices in Lisbon and London.

Picstars AG, established in 2014 and headquartered in Zürich, Switzerland, operates an online platform that connects brands with suitable influencers, particularly in the sports and lifestyle sectors. The company's core service involves helping brands identify and collaborate with appropriate brand ambassadors who can promote their products or services through their own social media channels. Picstars' platform enables brands to create and manage campaigns, track performance, and measure the success of their influencer marketing efforts. Recognized as one of the top 10 tech startups in Switzerland, Picstars aims to digitize the sponsorship of brand ambassadors, streamlining the process for both brands and influencers.

Yonder AG is a Swiss company, founded in 2015 and based in Zurich, that specializes in documentation-as-a-service (DaaS) solutions. The company's primary offering, Yonder Mind, is an application software designed for information management, enabling organizations to create, maintain, and deliver relevant content to users efficiently. Yonder AG also offers services related to document content creation and conversion, helping clients streamline information dissemination through shorter documents and manageable revisions.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, the company is dedicated to addressing the unmet medical needs of patients globally. Its lead candidate, VS-01, is in the preclinical stage and aims to be the first drug for acute liver disease, with the unique capability of supporting multiple organ function. VS-01 has received Orphan Drug Designation for acute liver failure, highlighting its potential in treating rare conditions. Additionally, Versantis is advancing other products in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent significant opportunities for improving patient outcomes in the field of liver health and beyond.

xorlab AG is a Swiss cybersecurity company established in 2015, specializing in advanced defense solutions for email communication. The company has developed the xorlab ActiveGuard platform, which protects organizations from sophisticated threats such as spear-phishing, impersonation, ransomware, and zero-day exploits. By analyzing and learning from legitimate communication behaviors, ActiveGuard enhances email security for businesses, particularly in the financial services and high-tech sectors. Additionally, xorlab offers xorlab ThreatAnalyst, which supports security operations teams in identifying and mitigating emerging attacks. With a dedicated team of 14 professionals, xorlab safeguards over 50,000 mailboxes and processes more than 1.5 million emails daily, helping clients reduce the risk of breaches and lower operational costs through automation and proactive defense strategies.

Wingtra AG, founded in 2014 and based in Zürich, Switzerland, specializes in the manufacture of professional drones, notably the WingtraOne, a vertical take-off and landing (VTOL) UAV. This drone is designed for high-precision data collection and has applications across various industries, including surveying, agriculture, forestry, and infrastructure management. Since its market introduction in 2017, Wingtra has established partnerships with over 50 major surveying equipment dealers globally, facilitating the adoption of its technology. The WingtraOne can be operated using WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into two-dimensional maps and three-dimensional models, thereby enhancing monitoring and inspection capabilities in sectors such as construction, mining, and environmental management.

Eyeware Tech SA, founded in 2016 and based in Martigny, Switzerland, specializes in developing advanced eye and head tracking software, known as GazeSense, which utilizes consumer cameras. This innovative technology is applicable across a variety of sectors, including social robotics, automotive, healthcare, gaming, and advertising. As a research spin-off from EPFL and the Idiap Research Institute, Eyeware focuses on creating platform-independent solutions that leverage proprietary computer vision algorithms and machine perception AI. These advancements enable cost-effective and reliable eye tracking without the need for specialized hardware. Eyeware's software allows devices to understand user attention and intention, facilitating more natural interactions between people and technology. The company’s offerings are designed to support a wide range of applications, positioning Eyeware as a key player in the integration of human perception technology into everyday consumer devices and services.

xorlab AG is a Swiss cybersecurity company established in 2015, specializing in advanced defense solutions for email communication. The company has developed the xorlab ActiveGuard platform, which protects organizations from sophisticated threats such as spear-phishing, impersonation, ransomware, and zero-day exploits. By analyzing and learning from legitimate communication behaviors, ActiveGuard enhances email security for businesses, particularly in the financial services and high-tech sectors. Additionally, xorlab offers xorlab ThreatAnalyst, which supports security operations teams in identifying and mitigating emerging attacks. With a dedicated team of 14 professionals, xorlab safeguards over 50,000 mailboxes and processes more than 1.5 million emails daily, helping clients reduce the risk of breaches and lower operational costs through automation and proactive defense strategies.

TOLREMO therapeutics AG is a biotechnology company based in Muttenz, Switzerland, that focuses on drug discovery and the development of therapies for cancer patients. Established in 2017, the company specializes in creating small molecules aimed at targeting novel pathways associated with drug resistance in cancer treatments. TOLREMO's innovative approach includes developing add-on therapies that enhance the effectiveness of existing oncogene-targeting drugs by dismantling the mechanisms that contribute to drug resistance. By eradicating cancer cells responsible for this resistance, TOLREMO aims to provide personalized anti-drug resistance therapies, ultimately improving patient response rates and prolonging the lives of those affected by cancer.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

Climeworks AG is a Swiss company founded in 2009 that specializes in developing and commercializing technology for capturing carbon dioxide (CO2) directly from the atmosphere. The company operates modular direct air capture plants that utilize filters and primarily low-grade heat as an energy source to extract CO2. This captured CO2 is then supplied to various industries, including commercial agriculture, food and beverage, energy, and automotive. Clients employ this atmospheric CO2 for applications such as carbonated drinks, carbon-neutral hydrocarbon fuels, and materials. Climeworks also supports businesses in achieving their climate objectives by providing solutions for reversing emissions and safely storing the captured CO2, contributing to global efforts to combat climate change.

ProteoMediX is a healthcare company focused on improving the diagnosis of prostate cancer through innovative biomarker signatures. Based in the Bio-Technopark of Zurich-Schlieren, Switzerland, the company has developed Proclarix®, a blood-based test panel that assesses the risk of prostate cancer and is currently available in Europe. This test aims to aid in the early detection of prostate cancer and provide insights into the cancer's stage, allowing for improved treatment strategies. By offering enhanced accuracy in distinguishing between aggressive and indolent cancers, ProteoMediX seeks to support physicians in making better-informed decisions for patient care.

Aspivix SA is a Swiss company specializing in the development of innovative medical devices aimed at enhancing gynecological procedures. Founded in 2015 and headquartered in Lausanne, Aspivix focuses on creating minimally invasive surgical instruments that prioritize patient comfort and safety. Its flagship product, CAREVIX, utilizes a patented suction technology to stabilize the cervix during procedures, effectively reducing pain and minimizing the risk of bleeding, lesions, and infections. This approach replaces traditional methods, such as the use of forceps, offering a gentler alternative for both women and gynecologists. Through its advancements, Aspivix aims to transform the landscape of gynecological care by making procedures safer and more efficient.

Uepaa AG, based in Zurich, Switzerland, specializes in peer-to-peer communication technology for mobile devices. Founded in 2012 by Mathias Haussmann and Dr. Franck Legendre, the company has developed an innovative software solution that allows mobile applications to establish direct connections, even in the absence of cellular or internet coverage. Its flagship product, the Uepaa! Safety app, launched in 2013, is designed to provide safety protection for lone workers and field employees by enabling features such as accident detection and emergency alerts. This app has become an industry standard for mobile-based safety solutions, serving thousands of users and meeting the growing demand for enhanced worker safety in various environments. Uepaa AG's technology platform, known as Proximity SDK p2pkit, allows devices to communicate and share information when in close proximity, further enhancing its applications in safety and emergency response.

TestingTime AG, founded in 2014 and based in Zurich, Switzerland, specializes in online recruitment services for test users, catering primarily to the UX and market research sectors. The company offers a diverse pool of over 350,000 participants, enabling clients to efficiently source individuals for usability tests, interviews, focus groups, and surveys in multiple languages, including German, French, Italian, Romansh, and English. By employing screening processes, predictive machine learning algorithms, and a smart rating system, TestingTime ensures the recruitment of high-quality test users with a low no-show rate. Its services are utilized by notable corporations such as UBS, Zalando, Microsoft, and Accenture, facilitating seamless research processes for their clients.

Polyneuron Pharmaceuticals AG is a biotechnology company based in Basel, Switzerland, founded in 2014. The company focuses on developing innovative therapeutics for antibody-mediated autoimmune disorders, particularly those affecting the peripheral nervous system. Its lead candidates include PN-1007 for anti-MAG neuropathy, PN-1018 for multifocal motor neuropathy, and PN-032 and PN-056 for ABO-incompatible transplantation. Polyneuron employs a unique platform technology called Antibody-Catch, which utilizes biodegradable glycopolymers to selectively target and eliminate pathogenic autoantibodies while preserving the overall integrity of the immune system. This approach aims to provide safe and effective treatment options for patients suffering from these complex immune disorders.

Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.

Abionic SA is a Swiss company specializing in nanotechnology-based diagnostic solutions aimed at enhancing medical diagnosis. Founded in 2010 as a spin-off from the Swiss Federal Institute of Technology Lausanne (EPFL), Abionic has developed the abioSCOPE platform, which enables rapid testing of patients' allergy profiles using just a single drop of blood. This innovative platform includes a reader for nanofluidic sensors and a smartphone application, facilitating both clinical laboratory use and point-of-care testing. Abionic's products are designed to assist healthcare professionals in diagnosing and screening various medical conditions, particularly in the realms of allergy and sepsis. The company is ISO 9001/13485 certified, demonstrating its commitment to quality management in the development and commercialization of in vitro diagnostic devices. With strategic support from various Swiss institutions, Abionic aims to become a significant player in personalized medicine on an international scale. The company is headquartered in Lausanne, Switzerland.

Piavita AG, founded in 2016 and based in Zurich, Switzerland, specializes in developing a matchbox-sized wearable device that precisely measures vital data in pets and horses. Recognizing the increasing demand for high-quality veterinary care, the company addresses the challenges faced by veterinarians in diagnosing and monitoring animal health due to limited information and outdated practices. Piavita's innovative solution includes a wearable technology that tracks vital signs through an animal's coat without the need for clipping, combined with a web-based application that enables real-time monitoring and historical data access. This system enhances communication between veterinarians and pet owners, aiming to lead the digital transformation in the veterinary industry by providing reliable insights into animal health.

Picstars AG, established in 2014 and headquartered in Zürich, Switzerland, operates an online platform that connects brands with suitable influencers, particularly in the sports and lifestyle sectors. The company's core service involves helping brands identify and collaborate with appropriate brand ambassadors who can promote their products or services through their own social media channels. Picstars' platform enables brands to create and manage campaigns, track performance, and measure the success of their influencer marketing efforts. Recognized as one of the top 10 tech startups in Switzerland, Picstars aims to digitize the sponsorship of brand ambassadors, streamlining the process for both brands and influencers.

embotech AG specializes in developing decision-making software solutions for autonomous systems. Founded in 2013 as a spin-off from the Automatic Control Laboratory at ETH Zurich, the company provides FORCES Pro, a numerical optimization software that enables the design of complex control systems. This software is utilized in various applications, including the control of wind turbines, planning the collision-free motion of autonomous drones, and the development of advanced driver assistance systems. Additionally, it supports precision landing of spacecraft on other planets and the recovery of reusable rockets. Embotech's solutions cater to sectors such as automotive, energy, and robotics, aiming to enhance safety, productivity, and energy efficiency in automated decision-making processes. The company is headquartered in Zurich, Switzerland.

QualySense AG is a Swiss company that specializes in the development and marketing of sorting devices for grains, seeds, and beans. Founded in 2009 and based in Glattbrugg, the company has created innovative high-throughput sorting technology capable of processing multiple tons per hour. Its flagship product, the QSorter Explorer, utilizes advanced techniques like hyperspectral near-infrared spectroscopy and machine vision to inspect and measure the biochemical and physical properties of individual kernels. This technology allows clients, including seed breeders, food companies, and inspection agencies, to classify grain batches based on quality and sell premium products at higher prices. By enhancing the accuracy and efficiency of grain processing, QualySense enables its customers to increase production value and improve product quality in a streamlined manner.

Apiax AG, founded in 2017 and based in Zürich, Switzerland, specializes in developing digital tools for managing financial regulations. The company provides an embedded compliance solution that allows financial institutions, including banks and FinTech companies, to transform complex regulations into user-friendly digital compliance rules. This technology enables clients to integrate compliance seamlessly into their existing applications and processes, facilitating faster decision-making and addressing pressing regulatory questions. By leveraging a high-performance architecture and machine learning, Apiax helps organizations navigate regulatory challenges, seize business opportunities, and reduce compliance costs. The company's presence extends beyond Switzerland, with additional offices in Lisbon and London.

Peripal AG is a medical device company based in Zurich, Switzerland, founded in 2015. It specializes in developing and commercializing patient aids for home care patients undergoing dialysis, particularly focusing on Peritoneal dialysis. Notable products include PeriSafe, a patient assist device designed to facilitate the Peritoneal dialysis process, and PERiPLEX, a diagnostic tool for detecting infections associated with this treatment. The company’s primary innovation, the Peripal System, enhances the manual connection of dialysis tubings, addressing the complexities and risks associated with traditional methods. By simplifying the connection process, Peripal aims to empower more patients to perform their dialysis at home, thereby alleviating anxiety for healthcare providers and reducing overall healthcare costs.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, the company is dedicated to addressing the unmet medical needs of patients globally. Its lead candidate, VS-01, is in the preclinical stage and aims to be the first drug for acute liver disease, with the unique capability of supporting multiple organ function. VS-01 has received Orphan Drug Designation for acute liver failure, highlighting its potential in treating rare conditions. Additionally, Versantis is advancing other products in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent significant opportunities for improving patient outcomes in the field of liver health and beyond.

ProteoMediX is a healthcare company focused on improving the diagnosis of prostate cancer through innovative biomarker signatures. Based in the Bio-Technopark of Zurich-Schlieren, Switzerland, the company has developed Proclarix®, a blood-based test panel that assesses the risk of prostate cancer and is currently available in Europe. This test aims to aid in the early detection of prostate cancer and provide insights into the cancer's stage, allowing for improved treatment strategies. By offering enhanced accuracy in distinguishing between aggressive and indolent cancers, ProteoMediX seeks to support physicians in making better-informed decisions for patient care.

Piavita AG, founded in 2016 and based in Zurich, Switzerland, specializes in developing a matchbox-sized wearable device that precisely measures vital data in pets and horses. Recognizing the increasing demand for high-quality veterinary care, the company addresses the challenges faced by veterinarians in diagnosing and monitoring animal health due to limited information and outdated practices. Piavita's innovative solution includes a wearable technology that tracks vital signs through an animal's coat without the need for clipping, combined with a web-based application that enables real-time monitoring and historical data access. This system enhances communication between veterinarians and pet owners, aiming to lead the digital transformation in the veterinary industry by providing reliable insights into animal health.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Polyneuron Pharmaceuticals AG is a biotechnology company based in Basel, Switzerland, founded in 2014. The company focuses on developing innovative therapeutics for antibody-mediated autoimmune disorders, particularly those affecting the peripheral nervous system. Its lead candidates include PN-1007 for anti-MAG neuropathy, PN-1018 for multifocal motor neuropathy, and PN-032 and PN-056 for ABO-incompatible transplantation. Polyneuron employs a unique platform technology called Antibody-Catch, which utilizes biodegradable glycopolymers to selectively target and eliminate pathogenic autoantibodies while preserving the overall integrity of the immune system. This approach aims to provide safe and effective treatment options for patients suffering from these complex immune disorders.

Fanpictor is a Swiss technology company specializing in digital and on-site fan engagement solutions tailored for brands and rights holders. The company develops innovative tools that facilitate unique, fan-driven experiences, fostering lasting connections between fans, teams, and brands. Fanpictor's platform allows marketing and creative teams to design targeted campaigns for specific events or series of competitions, utilizing location-specific strategies to enhance participation. Their solutions, which are fully customizable and can be integrated into existing apps, enable clients to collect and analyze commercially validated data to assess engagement and campaign effectiveness across different demographic segments. By leveraging these insights, Fanpictor helps create meaningful interactions that enhance the overall fan experience.

Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Medyria AG is a Swiss medtech company based in Winterthur, specializing in sensor-based catheter navigation and sensing systems for cardiovascular procedures. Founded in 2012, the company offers a range of innovative products, including a catheter positioning system designed for X-ray and C-dye free minimally invasive interventions, as well as Flowcath, which measures blood flow. Their Trackcath technology processes flow data to enhance catheter tracking, while their OEM flow sensor utilizes proprietary technology for measuring blood and physiological fluid flow. Medyria aims to enhance the safety and effectiveness of endovascular procedures, ultimately improving patient outcomes and reducing procedural complications and costs.

Bluetector AG, founded in 2012 and based in Root, Switzerland, specializes in manufacturing wastewater treatment machinery, particularly focused on the treatment of manure and biogas digestate. The company offers innovative containerized filtering systems that biologically purify wastewater, providing a cost-effective alternative to traditional disposal methods. By converting excess manure into clean water, Bluetector addresses the challenges faced by farmers who often have too much manure and insufficient land for spreading. This technology significantly reduces transportation costs associated with manure disposal, enabling farmers to manage their waste sustainably and economically. Additionally, Bluetector constructs and renovates municipal wastewater treatment plants, further contributing to effective wastewater management solutions.

Ampard AG, headquartered in Zurich, Switzerland, specializes in the development and marketing of the AMPARD energy management system across Europe. Established in 2011, the company focuses on managing distributed renewable power plants and demand response. The AMPARD system, a leading swarm energy management solution, optimizes control of renewable assets and storage systems, facilitates the creation of virtual power plants, and integrates other devices for demand response. Ampard's innovative technology enables efficient control and distribution of renewable energy, positioning it at the forefront of global innovation in the sector.

iMusician Digital AG is a Swiss-based online platform established in 2007 that provides musicians with comprehensive tools to sell, manage, and monetize their music. The platform simplifies the digital music distribution process, allowing artists to sell and stream their music across major applications while maintaining control over their copyrights. iMusician enables users to track sales in real-time, ensuring they can effectively manage their earnings and protect their intellectual property. With a small, dedicated international team passionate about music, the company focuses on supporting artists so they can prioritize their creative work.

Climeworks AG is a Swiss company founded in 2009 that specializes in developing and commercializing technology for capturing carbon dioxide (CO2) directly from the atmosphere. The company operates modular direct air capture plants that utilize filters and primarily low-grade heat as an energy source to extract CO2. This captured CO2 is then supplied to various industries, including commercial agriculture, food and beverage, energy, and automotive. Clients employ this atmospheric CO2 for applications such as carbonated drinks, carbon-neutral hydrocarbon fuels, and materials. Climeworks also supports businesses in achieving their climate objectives by providing solutions for reversing emissions and safely storing the captured CO2, contributing to global efforts to combat climate change.

ProteoMediX is a healthcare company focused on improving the diagnosis of prostate cancer through innovative biomarker signatures. Based in the Bio-Technopark of Zurich-Schlieren, Switzerland, the company has developed Proclarix®, a blood-based test panel that assesses the risk of prostate cancer and is currently available in Europe. This test aims to aid in the early detection of prostate cancer and provide insights into the cancer's stage, allowing for improved treatment strategies. By offering enhanced accuracy in distinguishing between aggressive and indolent cancers, ProteoMediX seeks to support physicians in making better-informed decisions for patient care.

Uepaa AG, based in Zurich, Switzerland, specializes in peer-to-peer communication technology for mobile devices. Founded in 2012 by Mathias Haussmann and Dr. Franck Legendre, the company has developed an innovative software solution that allows mobile applications to establish direct connections, even in the absence of cellular or internet coverage. Its flagship product, the Uepaa! Safety app, launched in 2013, is designed to provide safety protection for lone workers and field employees by enabling features such as accident detection and emergency alerts. This app has become an industry standard for mobile-based safety solutions, serving thousands of users and meeting the growing demand for enhanced worker safety in various environments. Uepaa AG's technology platform, known as Proximity SDK p2pkit, allows devices to communicate and share information when in close proximity, further enhancing its applications in safety and emergency response.

zkipster GmbH is an event management platform based in Zurich, Switzerland, founded in 2009. The company specializes in providing comprehensive tools for managing live, virtual, and hybrid events. Its offerings include a range of features such as guest list management, custom email and SMS communications, real-time session management, and dynamic seating charts. Additionally, zkipster's solutions enable efficient check-in processes through the use of QR codes and facilitate insightful event analysis. The platform is designed to enhance the guest experience and streamline event planning for global brands and renowned organizations. One of its key technologies is zFace, a picture matching search engine integrated into its guest list solution, which is accessible on various devices including iPads, iPhones, and Windows 8 systems.

Arviem AG provides comprehensive global trade monitoring and management services, focusing on cargo security and supply chain visibility. With a fully managed cargo security solution, the company offers in-transit monitoring for shipments across land, sea, and air, ensuring clients receive independent and reliable data on the location and condition of their cargo. Arviem's services encompass trade monitoring, analytics, and operations support, along with advisory services such as business consulting, system integration, and compliance. The company serves various sectors, including consumer products, pharmaceuticals, chemicals, and logistics, catering to importers, exporters, and logistics service providers in Europe, Asia, and the Americas. Arviem has established strategic partnerships with several technology firms to enhance its service offerings and optimize supply chain operations for its clients. Based in Rotkreuz, Switzerland, Arviem is dedicated to enabling real-time, data-driven decision-making for businesses engaged in global trade.

MySwissChocolate AG is a Swiss company that specializes in the production and marketing of custom-made chocolates. Established in 2010 and headquartered in Root, Switzerland, it operates an online platform that allows customers to create and order personalized chocolate products. The company distributes its offerings both within Switzerland and internationally, catering to a diverse clientele seeking unique chocolate experiences.

Creoptix AG is a Swiss company specializing in the development of advanced optical instruments and consumables for label-free analysis of molecular interactions, primarily serving the drug discovery sector. Founded in 2009 and headquartered in Wädenswil, with an additional office in the Boston area, Creoptix focuses on next-generation bioanalytical tools that enhance research capabilities in both industry and academia. Its flagship product, the Creoptix® WAVEsystem, utilizes proprietary Grating-Coupled Interferometry (GCI) technology to provide high sensitivity and resolution for studying real-time biological interactions involving various molecules, including small molecules, peptides, and membrane proteins, even in complex biofluids like serum or plasma. The company also offers versatile sensors and integrated software that streamline assay setup and data evaluation, making it easier for researchers to conduct molecular interaction studies.

SWISSto12 SA is a manufacturer of radio frequency (RF) and microwave components and systems, specializing in the production of various antenna types, including horn antennas, airborne Ku and Ka band antenna arrays, and slotted waveguide antennas. The company also offers polymer and metal waveguide products, along with a range of filter products, including diplexers and custom filters. Founded in 2011 as a spin-off from the Swiss Federal Institute of Technology in Lausanne, SWISSto12 utilizes innovative 3D printing techniques to create metal-coated components for (sub)mm-wave signal transmission, enhancing design flexibility while reducing costs and lead times. In addition to its manufacturing capabilities, the company provides integration and testing services, as well as a software solution for material properties extraction. SWISSto12 serves various sectors, including satellite communications, airborne satellites, and research centers, and has operations in Renens, Switzerland, as well as offices in Santa Clara, California, and Rehovot, Israel.

iMusician Digital AG is a Swiss-based online platform established in 2007 that provides musicians with comprehensive tools to sell, manage, and monetize their music. The platform simplifies the digital music distribution process, allowing artists to sell and stream their music across major applications while maintaining control over their copyrights. iMusician enables users to track sales in real-time, ensuring they can effectively manage their earnings and protect their intellectual property. With a small, dedicated international team passionate about music, the company focuses on supporting artists so they can prioritize their creative work.

Aeon Scientific AG is a medical device company based in Schlieren, Switzerland, that specializes in the development of innovative medical equipment utilizing patented electromagnetic steering technology. Founded in 2010, the company focuses on creating tools that enhance the effectiveness, safety, and minimally invasive nature of medical procedures, particularly in the field of electrophysiology. Its flagship product, Cmag, is a magnetic catheter steering system designed to assist electrophysiologists during catheter ablation procedures for treating arrhythmias like atrial fibrillation. By facilitating the precise movement of ablation catheters through the heart using magnetic fields, Aeon Scientific aims to improve patient outcomes while reducing healthcare costs. The company seeks to expand its offerings to include comprehensive toolkits for various medical applications and is open to partnerships with other medical device manufacturers to foster innovation in the industry.

Bluetector AG, founded in 2012 and based in Root, Switzerland, specializes in manufacturing wastewater treatment machinery, particularly focused on the treatment of manure and biogas digestate. The company offers innovative containerized filtering systems that biologically purify wastewater, providing a cost-effective alternative to traditional disposal methods. By converting excess manure into clean water, Bluetector addresses the challenges faced by farmers who often have too much manure and insufficient land for spreading. This technology significantly reduces transportation costs associated with manure disposal, enabling farmers to manage their waste sustainably and economically. Additionally, Bluetector constructs and renovates municipal wastewater treatment plants, further contributing to effective wastewater management solutions.